Reactive hypoglycemia

New Splenda® Diabetes Care Shakes: The First and Only Diabetes Shakes with No Added Sugar

Retrieved on: 
Wednesday, June 24, 2020

This combination works to help individuals manage blood sugar and help reduce blood sugar spikes, and to stay full longer.

Key Points: 
  • This combination works to help individuals manage blood sugar and help reduce blood sugar spikes, and to stay full longer.
  • Splenda Diabetes Care Shakes are high in fiber, soy free, gluten free and suitable for lactose intolerance.
  • As industry experts in cutting calories and carbohydrates from sugar without cutting taste, Splenda has developed the first and only no added sugar diabetes shake that's bursting with flavor.
  • Splenda Diabetes Care Shakes contain 16g of high-quality protein, a unique blend of slow-digesting carbohydrates and good-for-you monounsaturated fats to help manage blood sugar and reduce blood sugar spikes
    View original content to download multimedia: http://www.prnewswire.com/news-releases/new-splenda-diabetes-care-shakes...

Diet Demand’s Customized Diet Plans Help Manage Blood Sugar Levels for Patients at Risk for Diabetes

Retrieved on: 
Thursday, January 16, 2020

A low carb intake Since simple carbohydrates (white bread, white pasta, white rice, crackers) convert to sugar when digested, these foods can cause blood sugar spikes.

Key Points: 
  • A low carb intake Since simple carbohydrates (white bread, white pasta, white rice, crackers) convert to sugar when digested, these foods can cause blood sugar spikes.
  • Switching over to complex carbohydrates such as those found in vegetables can help you feel full as well as keep blood sugar controlled.
  • Thats why it is imperative check your blood sugar levels often and switch to a diet that better manages those levels if youre at risk for diabetes due to weight or family history.
  • Diet Demands program offers virtual weight loss assistance and prescription aids sent directly to your home for ultimate convenience and privacy.

Xeris Pharmaceuticals Announces Positive Topline Results From the In-clinic Stage of the Phase 2 Study of Its Developmental Ready-to-use (RTU) Glucagon in Patients at Risk of Postprandial Hypoglycemia Following Bariatric Surgery

Retrieved on: 
Tuesday, December 10, 2019

This is a Phase 2 prospective, randomized, placebo-controlled, double-blind study that comprises an in-clinic stage followed by a 12-week outpatient stage.

Key Points: 
  • This is a Phase 2 prospective, randomized, placebo-controlled, double-blind study that comprises an in-clinic stage followed by a 12-week outpatient stage.
  • The in-clinic stage is now complete, and this study is currently ongoing in the outpatient stage, where both subjects and investigators remain blinded.
  • For more information, visit www.clinicaltrials.gov Identifier: NCT03770637
    Results from the in-clinic stage of this Phase 2 study demonstrate that most subjects experienced postprandial hypoglycemia within 90-120 minutes after finishing the meal.
  • A mini dose of RTU glucagon was adequate to restore or maintain normal blood glucose levels within 15 minutes of administration.

Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study of Avexitide in Post-Bariatric Hypoglycemia (PBH) at Upcoming Endocrine Society (ENDO) Meeting 2019 in New Orleans

Retrieved on: 
Monday, February 4, 2019

Avexitide is a first in class glucagon-like peptide-1 (GLP-1) antagonist in development for PBH as a convenient, novel liquid formulation for SC administration.

Key Points: 
  • Avexitide is a first in class glucagon-like peptide-1 (GLP-1) antagonist in development for PBH as a convenient, novel liquid formulation for SC administration.
  • Lee, C. et al; "28-Day Dosing with Avexitide Improves Hyperinsulinemic Hypoglycemia in Patients with Severe, Refractory Post-Bariatric Hypoglycemia: The PREVENT Study", Oral Presentation, OR20-5, March 25, 2019, Room 291, 12:00-12:15 PM CST.
  • Avexitide is a 31-amino acid peptide that selectively targets and blocks GLP-1 receptors, normalizing insulin secretion by the pancreas, and thereby reducing postprandial hypoglycemia.
  • Eiger does not assume any obligation to update any forward-looking statements, except as required by law.

Advocate by Pharma Supply, Inc. Launches New Form of Rapid Glucose Delivery for Low Blood Sugar (Hypoglycemia)

Retrieved on: 
Tuesday, October 30, 2018

Low blood sugar (hypoglycemia) can be frightening for all involved.

Key Points: 
  • Low blood sugar (hypoglycemia) can be frightening for all involved.
  • Waiting for the body todigest candy, soda, or juice can feel like an eternity and panic often leads to over-treatmentand rebound high blood sugar.
  • This low-high blood sugar roller coaster reduces the quality oflife, decreases productivity and can result in long-term complications.
  • Simply pour the great tasting, pre-measuredpacket of ADA-recommended 15 grams of glucose powder into your mouth and absorptionstarts immediately!